Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Harrisburg Daily Digest.
Press releases published on May 15, 2025

Longevity Health Holdings Announces Business Updates
PITTSBURGH and GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on extending human longevity and healthy aging through technologically innovative and clinically proven products in …

DNB STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Dun & Bradstreet Holdings, Inc. (NYSE: DNB) Proposed Stockholder Buyout and Encourages Investors to Contact the Firm
PHILADELPHIA, May 15, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Dun …

BRDG STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Bridge Investment Group Holdings Inc. (NYSE: BRDG) Proposed Stockholder Buyout and Encourages Investors to Contact the Firm
PHILADELPHIA, May 15, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Bridge Investment Group Holdings Inc. (NYSE: BRDG) (“Bridge”) shareholders. Click here for …

AMRK STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of A-Mark Precious Metals, Inc. (NASDAQ: AMRK) Proposed Merger and Encourages Investors to Contact the Firm
PHILADELPHIA, May 15, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed merger between A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (“A-Mark”) and Spectrum Group International, Inc. …

CORA Group Announces the Appointment of Beth McCoy to President of CORA Loyalty
WARMINSTER, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- CORA Group (“CORA”), an operating portfolio of Jonas Software, a subsidiary of Constellation Software Inc., announced today that Beth McCoy was promoted to President of CORA Loyalty, reporting to Denis …

Palvella Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Phase 3 SELVA trial evaluating QTORIN™ 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin) for the treatment of microcystic lymphatic malformations (microcystic LMs) has exceeded enrollment target of 40 patients; enrollment expected to close in June 2025 …

Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
PITTSBURGH, May 15, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, and CLIA laboratory to …

Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
– Two subtype specific cohorts with ~15 patients each added to the ongoing RESET-Myositis™ trial – – RMAT designation granted for rese-cel in myositis, which is a disabling, multi-system autoimmune disease affecting approximately 80,000 U.S. …

Traws Pharma Reports First Quarter 2025 Results and Business Highlights
FDA briefing document submitted April 24, 2025 in support of a meeting to align on pathway for tivoxavir marboxil (TXM, bird flu/seasonal flu) including potential for accelerated approval utilizing the “Animal Rule” Additional briefing document in support …

Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting
Two Head-to-Head Randomized Trials Highlight Superior Early Patient Experience with the UroLift™ System for BPH1-2 First-Ever Analysis Utilizing the American Urological Association Quality Registry (AQUA) to Assess BPH Treatment Modalities Shows Strongest …